Tech-Enhanced Care Reduces Depression in Cancer Patients
The Intersection of Technology and Psycho-Oncology Care
Cancer Network2026.03.24Updated 11d ago
Jesse Fann, MD, MPH, provided insights on the SCOPE trial, which evaluated technology-enhanced collaborative care for depression in patients undergoing active cancer treatment.
AI SummaryPowered by AI
The SCOPE trial, led by Dr. Jesse Fann, demonstrates how technology-enabled collaborative care effectively treats depression in active cancer patients. This breakthrough integrates mental health support into oncology treatment, addressing a critical gap in psycho-oncology. Results suggest digital tools can significantly improve patient outcomes during cancer therapy.
Original Article
Read full article on Cancer Networkjesse fannscope trialpsycho-oncologycancer depressioncollaborative caretechnology-enhanced treatmentmental health oncologycareintersectiontechnology
Explore More
Related News
read, write and learn about any technology
HackerNoon · 2026.04.05
Technology and the New Logic of Growth
Daily Good Morning Kashmir · 2026.04.05
Investment Opportunities in the AI Technology Cycle
2026.04.05
Basic Space Technology: Basic Space Technology Summer Course completed
2026.04.04
Space Technology Conference - Central Eurasia, 2026
2026.04.04
Uzbekistan Space Technology Conference
2026.04.03